Funding for this research was provided by:
Agence Nationale de Recherches sur le Sida et les Hépatites Virales (ANRS 12381)
Received: 19 October 2021
Accepted: 12 November 2021
First Online: 4 December 2021
: The PRINCESSE protocol version 1.0 was submitted in November 2018 to the <i>Comité National d’Ethique des Sciences de la vie et de la santé de la Côte d’Ivoire</i> (CNESVS). The second version, including changes requested by CNESVS, was reviewed and approved on March 4th, 2019 (ref: 152–18/MSHP/CNESVS-km). The third version, introducing in-depth interviews by phone, was approved on March 15th, 2021. The fourth version, adding a biological component (specific objective 7), was approved on May 18th, 2021. These ethics approvals cover all study sites.The PRINCESSE project is registered on the Clinicaltrial.gov website (NCT03985085).Several consent forms are collected for the PRINCESSE study:UnorderedList removed
: Not applicable.
: The authors declare no competing interests.